Rainmed-B (02297) announced its results for the year ended December 31, 2023, and the group achieved acceptance during the period...
According to the Zhitong Finance App, Runmed-B (02297) announced the results for the year ended December 31, 2023. The group achieved revenue of 73.2 million yuan (RMB, same below) during the period, a year-on-year decrease of 12.4%; the loss attributable to the company's shareholders was 116 million yuan, a year-on-year decrease of 91.4%; and the basic loss per share was 0.1 yuan.
According to the announcement, the Group's gross profit decreased by about 30.4% from 69.8 million yuan for the year ended December 31, 2022 to 48.6 million yuan for the year ended December 31, 2023, mainly due to the decline in sales of the Group's CaffR system. The Group's gross margin fell from 83.5% for the year ended December 31, 2022 to 66.3% in the same period in 2023, mainly due to changes in product structure.